MacroGenics | MGNX - Ordinary Share Capital



MacroGenics reported $63.21M in Ordinary Share Capital for its fiscal quarter ending in June of 2025.


Ordinary Share Capital Change Date
AbbVie USD 18M 0 Dec/2024
Amgen USD 538M 33.04B Jun/2025
AstraZeneca USD 1.55B 1.16B Jun/2025
Biogen USD 146.6M 146.5M Jun/2025
Bristol-Myers Squibb USD 2.04B 1.74B Jun/2025
Daiichi Sankyo JPY 1.85B 48.15B Jun/2025
Eli Lilly USD 946.83M 354.23M Jun/2025
Genmab DKK 10M 56M Mar/2025
Geron USD 636.92M 636.28M Jun/2025
Gilead Sciences USD 1.24B 3M Jun/2025
J&J USD 3.12B 0 Mar/2025
MacroGenics USD 63.21M 62.58M Jun/2025
Merck USD 1.79B 0 Mar/2025
Pfizer USD 5.68B 5.2B Jun/2025
Regeneron Pharmaceuticals USD 106.4M 106.4M Jun/2025
Roche Holding CHF 107M 0 Jun/2024
Xencor USD 71.3M 70.58M Jun/2025